Bing Yu

Works at

National Heart, Lung, and Blood Institute
R01, Proteomic profiling of heart failure in Hispanics/Latinos, R01HL173837, 2025–2029, 20 May 2026
National Heart, Lung, and Blood Institute
R01, Molecular Determinants of Atherosclerotic Cardiovascular Disease in Multi-ethnic Populations, R01HL168683, 2023–2027, 10 Apr 2026
National Heart, Lung, and Blood Institute
R01, Premature aging disorders, metabolites, and atherosclerosis, R01HL163857, 2022–2027, 16 Feb 2026
National Institute on Aging
R01, Metal Exposures, Omics, and AD/ADRD risk in Diverse US Adults, R01AG093805, 2026–2030, 30 Jan 2026
National Institute of Diabetes and Digestive and Kidney Diseases
R01, Blood proteomic signatures of diabetes and gut dysbiosis, R01DK143633, 2026–2030, 28 Jan 2026
National Heart, Lung, and Blood Institute
R01, Circulating metabolites underlying cardiometabolic risk for cardiac dysfunction and heart failure in diverse populations, R01HL178090, 2025–2027, 24 Sept 2025
National Heart, Lung, and Blood Institute
R01, Genetic Architecture of Cardiac Structure and Function and Its Impact on Heart Failure, R01HL160793, 2022–2027, 10 Jul 2025
National Heart, Lung, and Blood Institute
R01, Proteomic signatures to identify pathways underlying the progression to heart failure, R01HL148218, 2023–2025, 29 Aug 2023